Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T14:40:57.574Z.
Calculation as of: 2026-10-06T14:40:57.574Z.
Quote observation: 2026-10-06T14:40:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 47c8a7f7872550f4b91559d6c77d4467729e005a9c3786f3e3eb9faa26d80d2a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2018-11-13.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
867.40x
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Avalo Therapeutics, Inc.
Market Cap
$723.83M
EV/EBITDA Ratio
N/A
TTM Avg
867.40x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$713.62M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$743.96M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$706.08M
EV/EBITDA Ratio
2.84x
TTM Avg
4.78x
3Y Avg
5.46x
5Y Avg
7.57x
Market Cap
$727.72M
EV/EBITDA Ratio
N/A
TTM Avg
316.20x
3Y Avg
225.87x
5Y Avg
225.87x
Market Cap
$747.00M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$745.42M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$695.21M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$766.63M
EV/EBITDA Ratio
18.43x
TTM Avg
16.06x
3Y Avg
17.33x
5Y Avg
27.55x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | $723.83M | N/A | 867.40x | N/A | N/A |
| Achieve Life Sciences, Inc. (ACHV)vs › | $713.62M | N/A | N/A | N/A | N/A |
| Candel Therapeutics, Inc. (CADL)vs › | $743.96M | N/A | N/A | N/A | N/A |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $706.08M | 2.84x | 4.78x | 5.46x | 7.57x |
| Cytek Biosciences, Inc. (CTKB)vs › | $727.72M | N/A | 316.20x | 225.87x | 225.87x |
| Attovia Therapeutics, Inc. (ATTO)vs › | $747.00M | N/A | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $745.42M | N/A | N/A | N/A | N/A |
| Anteris Technologies Global Corp. (AVR)vs › | $695.21M | N/A | N/A | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $766.63M | 18.43x | 16.06x | 17.33x | 27.55x |
| Faeth Therapeutics, Inc. (FTH)vs › | $678.96M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2018-11-13 | 12.51x |
| 2018-11-12 | 12.92x |
| 2018-11-09 | 13.94x |
| 2018-11-08 | 14.32x |
| 2018-11-07 | 14.35x |
| 2018-11-06 | 13.94x |
| 2018-11-05 | 14.47x |
| 2018-11-02 | 14.12x |
| 2018-11-01 | 14.32x |
| 2018-10-31 | 13.21x |
| 2018-10-30 | 12.27x |
| 2018-10-29 | 12.54x |
| 2018-10-26 | 12.74x |
| 2018-10-25 | 12.92x |
| 2018-10-24 | 12.60x |
| 2018-10-23 | 13.42x |
| 2018-10-22 | 13.80x |
| 2018-10-19 | 14.44x |
| 2018-10-18 | 14.30x |
| 2018-10-17 | 14.50x |
| 2018-10-16 | 14.59x |
| 2018-10-15 | 14.65x |
| 2018-10-12 | 14.73x |
| 2018-10-11 | 14.62x |
| 2018-10-10 | 13.97x |
| 2018-10-09 | 14.03x |
| 2018-10-08 | 14.09x |
| 2018-10-05 | 14.50x |
| 2018-10-04 | 13.97x |
| 2018-10-03 | 14.21x |
| 2018-10-02 | 14.00x |
| 2018-10-01 | 14.85x |
| 2018-09-28 | 14.88x |
| 2018-09-27 | 15.00x |
| 2018-09-26 | 14.79x |
| 2018-09-25 | 14.53x |
| 2018-09-24 | 14.71x |
| 2018-09-21 | 13.80x |
| 2018-09-20 | 15.03x |
| 2018-09-19 | 14.32x |
| 2018-09-18 | 15.03x |
| 2018-09-17 | 14.56x |
| 2018-09-14 | 14.56x |
| 2018-09-13 | 15.17x |
| 2018-09-12 | 15.09x |
| 2018-09-11 | 15.17x |
| 2018-09-10 | 14.65x |
| 2018-09-07 | 14.27x |
| 2018-09-06 | 14.41x |
| 2018-09-05 | 15.09x |
| 2018-09-04 | 15.20x |
| 2018-08-31 | 15.35x |
| 2018-08-30 | 15.55x |
| 2018-08-29 | 15.85x |
| 2018-08-28 | 15.55x |
| 2018-08-27 | 15.26x |
| 2018-08-24 | 15.26x |
| 2018-08-23 | 15.53x |
| 2018-08-22 | 15.85x |
| 2018-08-21 | 15.29x |
| 2018-08-20 | 14.30x |
| 2018-08-17 | 12.66x |
| 2018-08-16 | 12.66x |
| 2018-08-15 | 13.09x |
| 2018-08-14 | 13.01x |
| 2018-08-13 | 12.68x |
| 2018-08-10 | 14.27x |
| 2018-08-09 | 10.60x |
| 2018-08-08 | 11.40x |
| 2018-08-07 | 11.24x |
| 2018-08-06 | 11.12x |
| 2018-08-03 | 11.53x |
| 2018-08-02 | 11.28x |
| 2018-08-01 | 10.99x |
| 2018-07-31 | 11.06x |
| 2018-07-30 | 10.96x |
| 2018-07-27 | 10.96x |
| 2018-07-26 | 11.49x |
| 2018-07-25 | 11.51x |
| 2018-07-24 | 11.01x |
| 2018-07-23 | 11.53x |
| 2018-07-20 | 11.56x |
| 2018-07-19 | 11.47x |
| 2018-07-18 | 10.87x |
| 2018-07-17 | 10.92x |
| 2018-07-16 | 10.65x |
| 2018-07-13 | 10.35x |
| 2018-07-12 | 11.19x |
| 2018-07-11 | 11.10x |
| 2018-07-10 | 11.37x |
| 2018-07-09 | 11.58x |
| 2018-07-06 | 11.81x |
| 2018-07-05 | 11.88x |
| 2018-07-03 | 11.49x |
| 2018-07-02 | 10.85x |
| 2018-06-29 | 10.83x |
| 2018-06-28 | 10.78x |
| 2018-06-27 | 11.35x |
| 2018-06-26 | 11.51x |
| 2018-06-25 | 11.44x |
| 2018-06-22 | 12.13x |
| 2018-06-21 | 12.08x |
| 2018-06-20 | 12.08x |
| 2018-06-19 | 11.90x |
| 2018-06-18 | 12.20x |
| 2018-06-15 | 11.85x |
| 2018-06-14 | 11.99x |
| 2018-06-13 | 11.40x |
| 2018-06-12 | 10.58x |
| 2018-06-11 | 10.55x |
| 2018-06-08 | 10.71x |
| 2018-06-07 | 10.69x |
| 2018-06-06 | 10.78x |
| 2018-06-05 | 10.94x |
| 2018-06-04 | 10.69x |
| 2018-06-01 | 10.55x |
| 2018-05-31 | 10.39x |
| 2018-05-30 | 10.76x |
| 2018-05-29 | 9.96x |
| 2018-05-25 | 9.80x |
| 2018-05-24 | 9.92x |
| 2018-05-23 | 9.69x |
| 2018-05-22 | 9.73x |
| 2018-05-21 | 9.48x |
| 2018-05-18 | 9.85x |
| 2018-05-17 | 9.71x |
| 2018-05-16 | 9.44x |
| 2018-05-15 | 9.39x |
| 2018-05-14 | 8.98x |
| 2018-05-11 | 1834.51x |
| 2018-05-10 | 2038.94x |
| 2018-05-09 | 2065.15x |
| 2018-05-08 | 2154.26x |
| 2018-05-07 | 2154.26x |
| 2018-05-04 | 2117.57x |
| 2018-05-03 | 2101.84x |
| 2018-05-02 | 2149.02x |
| 2018-05-01 | 2033.70x |
| 2018-04-30 | 1949.83x |
| 2018-04-27 | 2122.81x |
| 2018-04-26 | 2206.68x |
| 2018-04-25 | 2238.14x |
| 2018-04-24 | 2353.46x |
| 2018-04-23 | 2190.96x |
| 2018-04-20 | 2044.18x |
| 2018-04-19 | 1871.20x |
| 2018-04-18 | 1792.57x |
| 2018-04-17 | 1829.26x |
| 2018-04-16 | 1792.57x |
| 2018-04-13 | 1939.34x |
| 2018-04-12 | 1976.04x |
| 2018-04-11 | 2012.73x |
| 2018-04-10 | 2091.36x |
| 2018-04-09 | 2054.67x |
| 2018-04-06 | 2169.99x |
| 2018-04-05 | 2285.31x |
| 2018-04-04 | 2243.38x |
| 2018-04-03 | 2248.62x |
| 2018-04-02 | 2218.09x |
| 2018-03-29 | 2212.93x |
| 2018-03-28 | 2016.78x |
| 2018-03-27 | 2187.12x |
| 2018-03-26 | 2223.25x |
| 2018-03-23 | 2290.35x |
| 2018-03-22 | 2440.04x |
| 2018-03-21 | 2507.14x |
| 2018-03-20 | 2651.67x |
| 2018-03-19 | 2713.61x |
| 2018-03-16 | 2698.13x |
| 2018-03-15 | 2718.77x |
| 2018-03-14 | 2677.48x |
| 2018-03-13 | 2584.57x |
| 2018-03-12 | 2656.83x |
| 2018-03-09 | 2791.04x |
| 2018-03-08 | 2775.55x |
| 2018-03-07 | 2920.08x |
| 2018-03-06 | 2656.83x |
| 2018-03-05 | 2491.66x |
| 2018-03-02 | 2543.28x |
| 2018-03-01 | 2280.03x |
| 2018-02-28 | 2403.91x |
| 2018-02-27 | 2692.97x |
| 2018-02-26 | 2553.60x |
| 2018-02-23 | 2269.71x |
| 2018-02-22 | 2087.50x |
| 2018-02-21 | 2089.05x |
| 2018-02-20 | 2001.30x |
| 2018-02-16 | 2083.88x |
| 2018-02-15 | 1934.19x |
| 2018-02-14 | 2037.43x |
| 2018-02-13 | 1748.37x |
| 2018-02-12 | 1727.73x |
| 2018-02-09 | 1572.88x |
| 2018-02-08 | 1707.08x |
| 2018-02-07 | 1784.51x |
| 2018-02-06 | 1619.33x |
| 2018-02-05 | 1686.43x |
| 2018-02-02 | 1547.07x |
| 2018-02-01 | 1640.49x |
| 2018-01-31 | 1707.08x |
| 2018-01-30 | 1738.05x |
| 2018-01-29 | 1841.28x |
| 2018-01-26 | 1789.67x |
| 2018-01-25 | 1789.67x |
| 2018-01-24 | 1645.14x |
| 2018-01-23 | 1815.48x |
| 2018-01-22 | 1655.46x |
| 2018-01-19 | 1516.10x |
| 2018-01-18 | 1361.25x |
| 2018-01-17 | 1371.57x |
| 2018-01-16 | 1340.60x |
| 2018-01-12 | 1412.86x |
| 2018-01-11 | 1392.22x |
| 2018-01-10 | 1154.78x |
| 2018-01-09 | 1304.47x |
| 2018-01-08 | 1433.51x |
| 2018-01-05 | 1536.74x |
| 2018-01-04 | 1650.30x |
| 2018-01-03 | 1676.11x |
| 2018-01-02 | 1717.40x |
| 2017-12-29 | 1650.30x |
| 2017-12-28 | 1717.40x |
| 2017-12-27 | 2083.88x |
| 2017-12-26 | 1712.24x |
| 2017-12-22 | 1562.55x |
| 2017-12-21 | 1397.38x |
| 2017-12-20 | 1294.14x |
| 2017-12-19 | 1314.79x |
| 2017-12-18 | 1118.65x |
| 2017-12-15 | 999.93x |
| 2017-12-14 | 984.44x |
| 2017-12-13 | 1032.96x |
| 2017-12-12 | 963.79x |
| 2017-12-11 | 907.02x |
| 2017-12-08 | 865.72x |
| 2017-12-07 | 839.91x |
| 2017-12-06 | 772.81x |
| 2017-12-05 | 850.24x |
| 2017-12-04 | 917.34x |
| 2017-12-01 | 896.69x |
| 2017-11-30 | 917.34x |
| 2017-11-29 | 927.66x |
| 2017-11-28 | 679.90x |
| 2017-11-27 | 855.40x |
| 2017-11-24 | 607.64x |
| 2017-11-22 | 607.64x |
| 2017-11-21 | 602.47x |
| 2017-11-20 | 607.64x |
| 2017-11-17 | 581.83x |
| 2017-11-16 | 561.18x |
| 2017-11-15 | 571.50x |
| 2017-11-14 | 540.53x |
| 2017-11-13 | 519.89x |
| 2017-11-10 | 514.73x |
| 2017-11-09 | 545.70x |
| 2017-11-08 | 545.70x |
| 2017-11-07 | 566.34x |
